Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts

Similar Items

• Antiretroviral treatment and expression of the mRNA levels for Pgp, MRP1, MRP4 and MRP5 in HIV antiretroviral naïve patients. Follow-up at 48 weeks
  od: Falasca, Francesca, i dr.
  Izdano: (2010)
• PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR
  od: Anreddy, Nagaraju, i dr.
  Izdano: (2014)
• Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
  od: Erhabor, Osaro, i dr.
  Izdano: (2009)
• Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport
  od: Evers, R, i dr.
  Izdano: (2000)
• Changing antiretrovirals whilst viral load <50 copies/ml and relationship with CD4 count changes
  od: Mocroft, A
  Izdano: (2010)